Sanofi
Sanofi
0,00 %
75,98 EUR
0,00
Kurs
75,98
Hög
76,40
Förändring
0,00 %
Låg
75,37
Uppdaterad
2019-06-14
Öppen
75,68
Factsheet for Sanofi
Company Profile
Description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales.
Key Stats
Website: http://www.sanofi.com
Headquarter country: France
Employees: 112 128
Market Cap (at close 14-06-2019): EUR 95B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 23,60 19,90 24,60 19,60 24,50
Forward Price/Earnings 13,10 12,40 13,90 14,00 18,90
Price/Free Cash Flow 19,60 15,40 20,20 15,40 16,20
Return on Assets 4,10 8,20 4,50 4,30 4,50
Return on Equity 7,40 14,60 8,10 7,50 7,80
Return on Invested Capital 5,80 11,50 7,10 6,30 6,60
Dividend


Dividend/Share:3,00
Ex. Dividend Date:2018-12-31
Trailing Dividend Yield:4,04
Payout Ratio:103,46
Date Currency Amount
2018-06-30 EUR 3,03
2017-06-30 EUR 2,96
2016-06-30 EUR 2,93
2013-06-30 EUR 2,77
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 35 677,00 36 204,00 34 708,00 34 861,00 34 109,00
Gross Profit 24,24 24,59 24,01 23,94 23,08
Gross Margin % 67,95% 67,93% 69,17% 68,68% 67,67%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 9 119,00 9 636,00 9 903,00 10 078,00 10 113,00
Net income 4 306,00 8 434,00 4 709,00 4 287,00 4 390,00
Basic Earnings Per Share 3,45 6,71 3,66 3,28 3,34
Operating Income 6,26 7,20 7,53 7,13 6,83
Operating Margin % 17,53% 19,89% 21,69% 20,46% 20,03%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 5 547,00 7 379,00 7 838,00 8 920,00 7 690,00
Capital Expenditures -1 977,00 -1 956,00 -2 083,00 -2 772,00 -1 557,00
Free Cash Flow 3 570,00 5 423,00 5 755,00 6 148,00 6 133,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 24 647,00 26 386,00 33 108,00 30 680,00 23 437,00 23 926,00
Long Term Assets 86 761,00 73 440,00 71 564,00 71 641,00 73 955,00 72 139,00
Total Assets 111 408,00 99 826,00 104 672,00 102 321,00 97 392,00 96 065,00
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 17 376,00 15 457,00 17 629,00 17 808,00 13 032,00 13 958,00
Long Term Liabilities 26 280,00 30 684,00 26 464,00
Total Liabilities 41 737,00 47 118,00 44 272,00
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings
Treasury Stock 153,00 14,00 1 503,00 298,00 694,00 244,00
Total Stockholder Equity 58 876,00 58 089,00 57 554,00 58 049,00 56 120,00 56 885,00
Net Tangible Assets -7 248,00 4 745,00 6 388,00 6 466,00 2 380,00 4 356,00